Cargando…
Current Advances in CETSA
Knowing that the drug candidate binds to its intended target is a vital part of drug discovery. Thus, several labeled and label-free methods have been developed to study target engagement. In recent years, the cellular thermal shift assay (CETSA) with its variations has been widely adapted to drug d...
Autor principal: | Tolvanen, Tuomas Aleksi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9218591/ https://www.ncbi.nlm.nih.gov/pubmed/35755818 http://dx.doi.org/10.3389/fmolb.2022.866764 |
Ejemplares similares
-
CNS-Targeting Therapies for Lysosomal Storage Diseases: Current Advances and Challenges
por: Edelmann, Mariola J., et al.
Publicado: (2020) -
Current Advances on Structure-Function Relationships of Pyridoxal 5′-Phosphate-Dependent Enzymes
por: Liang, Jing, et al.
Publicado: (2019) -
Erratum: Structure of the Complete Dimeric Human GDAP1 Core Domain Provides Insights Into Ligand Binding and Clustering of Disease Mutations
por: Tuyet Nguyen, Giang Thi, et al.
Publicado: (2022) -
Structure of the Complete Dimeric Human GDAP1 Core Domain Provides Insights into Ligand Binding and Clustering of Disease Mutations
por: Nguyen, Giang Thi Tuyet, et al.
Publicado: (2021) -
CETSA-based target engagement of taxanes as biomarkers for efficacy and resistance
por: Langebäck, Anette, et al.
Publicado: (2019)